Abstract
Cutaneous lesions of lupus erythematosus (LE) may persist despite aggressive therapy with topical and systemic agents. To determine the efficacy of 0.1% tacrolimus ointment in such cases, researchers treated 12 patients who had treatment-resistant lesions of various types with the agent in an open-label study. …
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
